Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Omics Approaches in Pancreatic Adenocarcinoma.

González-Borja I, Viúdez A, Goñi S, Santamaria E, Carrasco-García E, Pérez-Sanz J, Hernández-García I, Sala-Elarre P, Arrazubi V, Oyaga-Iriarte E, Zárate R, Arévalo S, Sayar O, Vera R, Fernández-Irigoyen J.

Cancers (Basel). 2019 Jul 25;11(8). pii: E1052. doi: 10.3390/cancers11081052. Review.

2.

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα.

Liang N, Damdimopoulos A, Goñi S, Huang Z, Vedin LL, Jakobsson T, Giudici M, Ahmed O, Pedrelli M, Barilla S, Alzaid F, Mendoza A, Schröder T, Kuiper R, Parini P, Hollenberg A, Lefebvre P, Francque S, Van Gaal L, Staels B, Venteclef N, Treuter E, Fan R.

Nat Commun. 2019 Apr 11;10(1):1684. doi: 10.1038/s41467-019-09524-z.

3.

Preparation of Frozen Liver Tissues for Integrated Omics Analysis.

Liang N, Fan R, Goñi S, Treuter E.

Methods Mol Biol. 2019;1951:167-178. doi: 10.1007/978-1-4939-9130-3_13.

PMID:
30825152
4.

Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease.

Becares N, Gage MC, Voisin M, Shrestha E, Martin-Gutierrez L, Liang N, Louie R, Pourcet B, Pello OM, Luong TV, Goñi S, Pichardo-Almarza C, Røberg-Larsen H, Diaz-Zuccarini V, Steffensen KR, O'Brien A, Garabedian MJ, Rombouts K, Treuter E, Pineda-Torra I.

Cell Rep. 2019 Jan 22;26(4):984-995.e6. doi: 10.1016/j.celrep.2018.12.094.

5.

Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.

Fan R, Toubal A, Goñi S, Drareni K, Huang Z, Alzaid F, Ballaire R, Ancel P, Liang N, Damdimopoulos A, Hainault I, Soprani A, Aron-Wisnewsky J, Foufelle F, Lawrence T, Gautier JF, Venteclef N, Treuter E.

Nat Med. 2016 Jul;22(7):780-91. doi: 10.1038/nm.4114. Epub 2016 Jun 6.

PMID:
27270589
6.

Nuclear Receptor Coregulators in Metabolism and Disease.

Giudici M, Goni S, Fan R, Treuter E.

Handb Exp Pharmacol. 2016;233:95-135. doi: 10.1007/164_2015_5. Review.

PMID:
25903414
7.

Splicing regulator SLU7 is essential for maintaining liver homeostasis.

Elizalde M, Urtasun R, Azkona M, Latasa MU, Goñi S, García-Irigoyen O, Uriarte I, Segura V, Collantes M, Di Scala M, Lujambio A, Prieto J, Ávila MA, Berasain C.

J Clin Invest. 2014 Jul;124(7):2909-20. doi: 10.1172/JCI74382. Epub 2014 May 27.

8.

Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation.

Urtasun R, Latasa MU, Demartis MI, Balzani S, Goñi S, Garcia-Irigoyen O, Elizalde M, Azcona M, Pascale RM, Feo F, Bioulac-Sage P, Balabaud C, Muntané J, Prieto J, Berasain C, Avila MA.

Hepatology. 2011 Dec;54(6):2149-58. doi: 10.1002/hep.24587.

PMID:
21800344
9.

Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.

Latasa MU, Gil-Puig C, Fernández-Barrena MG, Rodríguez-Ortigosa CM, Banales JM, Urtasun R, Goñi S, Méndez M, Arcelus S, Juanarena N, Recio JA, Lotersztajn S, Prieto J, Berasain C, Corrales FJ, Lecanda J, Avila MA.

PLoS One. 2010 Dec 29;5(12):e15690. doi: 10.1371/journal.pone.0015690.

10.

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.

Berasain C, Ujue Latasa M, Urtasun R, Goñi S, Elizalde M, Garcia-Irigoyen O, Azcona M, Prieto J, Avila MA.

Cancers (Basel). 2011 May 18;3(2):2444-61. doi: 10.3390/cancers3022444.

11.

Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.

Berasain C, Goñi S, Castillo J, Latasa MU, Prieto J, Avila MA.

World J Gastroenterol. 2010 Jul 7;16(25):3091-102. Review.

12.

Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.

Castillo J, Goñi S, Latasa MU, Perugorría MJ, Calvo A, Muntané J, Bioulac-Sage P, Balabaud C, Prieto J, Avila MA, Berasain C.

Gastroenterology. 2009 Nov;137(5):1805-15.e1-4. doi: 10.1053/j.gastro.2009.07.065. Epub 2009 Aug 5.

PMID:
19664633
13.

The epidermal growth factor receptor: a link between inflammation and liver cancer.

Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, Prieto J, Avila MA.

Exp Biol Med (Maywood). 2009 Jul;234(7):713-25. doi: 10.3181/0901-MR-12. Epub 2009 May 8. Review.

PMID:
19429859
14.

Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.

Cancer Res. 2009 Feb 15;69(4):1358-67. doi: 10.1158/0008-5472.CAN-08-2545. Epub 2009 Feb 3.

15.

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.

Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Lotersztajn S, Prieto J, Berasain C, Avila MA.

Hepatology. 2008 Oct;48(4):1251-61. doi: 10.1002/hep.22437.

PMID:
18634036
16.

Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury.

Iñiguez M, Dotor J, Feijoo E, Goñi S, Prieto J, Berasain C, Avila MA.

Recent Pat Cardiovasc Drug Discov. 2008 Jan;3(1):9-18. Review.

PMID:
18221124

Supplemental Content

Loading ...
Support Center